Vilacto Bio Inc. (VIBI) financial statements (2020 and earlier)

Company profile

Business Address FABRIKSVEJ 48
NAESTVED, 4700
State of Incorp. NV
Fiscal Year End March 31
SIC 2844 - Perfumes, Cosmetics, and Other Toilet Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments257149220 14
Cash and cash equivalents257149220 14
Receivables00    
Inventory, net of allowances, customer advances and progress billings119100   
Inventory119100    
Prepaid expense 600   
Total current assets:376309220 14
Noncurrent Assets
Intangible assets, net (including goodwill)150    
Intangible assets, net (excluding goodwill)150     
Prepaid expense 60    
Other undisclosed noncurrent assets11(59)    
Total noncurrent assets:1611    
TOTAL ASSETS:538310220 14
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities76369330
Accounts payable76369330
Derivative instruments and hedges, liabilities1,227730    
Due to related parties176241122  
Other undisclosed current liabilities2,48123955 6 
Total current liabilities:3,9601,246652590
Noncurrent Liabilities
Long-term debt and lease obligation2,000     
Long-term debt, excluding current maturities2,000     
Other undisclosed noncurrent liabilities(2,000)     
Total liabilities:3,9601,246652590
Stockholders' equity
Stockholders' equity attributable to parent, including:(3,423)(936)(43)(25)(9)13
Preferred stock3     
Common stock5979090666
Additional paid in capital3,820(22)(22)595959
Accumulated deficit(7,858)(1,004)(111)(90)(74) 
Other undisclosed stockholders' equity attributable to parent15    (52)
Total stockholders' equity:(3,423)(936)(43)(25)(9)13
TOTAL LIABILITIES AND EQUITY:538310220 14

Income statement (P&L) ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Revenues51    
Cost of revenue(4)(1)    
Gross profit:11    
Operating expenses(971)(382)(21)(5)(5)(10)
Other operating expense, net
(Other Expenses)
(5,884)(512)(0)   
Other undisclosed operating income5,88451209579 
Operating income (loss):(970)(382)(21)9074(10)
Interest and debt expense(1,133)(47)(0)   
Income (loss) from continuing operations before equity method investments, income taxes:(2,103)(429)(21)9074(10)
Other undisclosed loss from continuing operations before income taxes   (105)(96)(41)
Net loss:(2,103)(429)(21)(16)(22)(51)
Other undisclosed net loss attributable to parent (465)    
Net loss attributable to parent:(2,103)(893)(21)(16)(22)(51)
Preferred stock dividends and other adjustments(60)     
Net loss available to common stockholders, diluted:(2,163)(893)(21)(16)(22)(51)

Comprehensive Income ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
3/31/2014
Net loss:(2,103)(429)(21)(16)(22)(51)
Comprehensive loss, net of tax, attributable to parent:(2,103)(429)(21)(16)(22)(51)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: